Cargando…

Development of dendritic cell loaded MAGE-A2 long peptide; a potential target for tumor-specific T cell-mediated prostate cancer immunotherapy

BACKGROUND: Prostate cancer (PCa) is the second leading cause of cancer-related deaths among men worldwide. Immunotherapy is an emerging treatment modality for cancers that harnesses the immune system’s ability to eliminate tumor cells. In particular, dendritic cell (DC) vaccines, have demonstrated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bakhshi, Parisa, Nourizadeh, Maryam, Sharifi, Laleh, Farajollahi, Mohammad M., Mohsenzadegan, Monireh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638778/ https://www.ncbi.nlm.nih.gov/pubmed/37951911 http://dx.doi.org/10.1186/s12935-023-03108-0

Ejemplares similares

Co-expression of cancer-testis antigens of MAGE-A6 and MAGE-A11 is associated with tumor aggressiveness in patients with bladder cancer
por: Mohsenzadegan, Monireh, et al.
Publicado: (2022)

Publisher Correction: Co-expression of cancer-testis antigens of MAGE-A6 and MAGE-A11 is associated with tumor aggressiveness in patients with bladder cancer
por: Mohsenzadegan, Monireh, et al.
Publicado: (2022)

Study of NGEP expression in androgen sensitive prostate cancer cells: A potential target for immunotherapy
por: Mohsenzadegan, Monireh, et al.
Publicado: (2015)

In-vitro prostate cancer biomarker detection by directed conjugation of anti-PSCA antibody to super paramagnetic iron oxide nanoparticless
por: Shahrabi Farahani, Mahboube, et al.
Publicado: (2019)

Epitope Prediction by Novel Immunoinformatics Approach: A State-of-the-art Review
por: Raoufi, Ehsan, et al.
Publicado: (2019)

MAGE-A3-specific anticancer immunotherapy in the clinical practice
por: Brichard, Vincent G, et al.
Publicado: (2013)

MAGE-A Antigens and Cancer Immunotherapy
por: Zajac, Paul, et al.
Publicado: (2017)

Fabrication of Antibody Conjugated Super Magnetic Oxide Nanoparticles for Early Detection of Prostate Cancer
por: Nayerpour dizaj, Tina, et al.
Publicado: (2023)

GK-1 Improves the Immune Response Induced by Bone Marrow Dendritic Cells Loaded with MAGE-AX in Mice with Melanoma
por: Piñón-Zárate, Gabriela, et al.
Publicado: (2014)

Immunoediting in SARS-CoV-2: Mutual relationship between the virus and the host
por: Kheshtchin, Nasim, et al.
Publicado: (2022)

Combined treatment with epigenetic agents enhances anti-tumor activity of MAGE-D4 peptide-specific T cells by upregulating the MAGE-D4 expression in glioma
por: Bi, Shui-Qing, et al.
Publicado: (2022)

Corrigendum to “GK-1 Improves the Immune Response Induced by Bone Marrow Dendritic Cells Loaded with MAGE-AX in Mice with Melanoma”
por: Piñón-Zárate, Gabriela, et al.
Publicado: (2015)

Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells
por: Mou, D-C, et al.
Publicado: (2002)

Dendritic Cell-Based Immunotherapy for Prostate Cancer
por: Jähnisch, Hanka, et al.
Publicado: (2010)

In vivo enhancement of the MAGE-specific cellular immune response by a recombinant MAGE1-MAGE3-TBHSP70 tumor vaccine
por: Junwei, Wang, et al.
Publicado: (2016)

Structural insights into engineering a T-cell receptor targeting MAGE-A10 with higher affinity and specificity for cancer immunotherapy
por: Simister, Philip C, et al.
Publicado: (2022)

Erratum to: In vivo enhancement of the MAGE-specific cellular immune response by a recombinant MAGE1-MAGE3-TBHSP70 tumor vaccine
por: Junwei, Wang, et al.
Publicado: (2017)

Tocilizumab for treatment patients with COVID-19: Recommended medication for novel disease
por: Samaee, Hamidreza, et al.
Publicado: (2020)

Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma
por: Thurner, Beatrice, et al.
Publicado: (1999)

Dendritic cells loaded with tumor derived exosomes for cancer immunotherapy
por: Liu, Hongyu, et al.
Publicado: (2017)

Correction: Structural insights into engineering a T-cell receptor targeting MAGE-A10 with higher affinity and specificity for cancer immunotherapy
Publicado: (2022)

The Inhibitory Role of M2000 (β-D-Mannuronic Acid) on Expression of Toll-like Receptor 2 and 4 in HT29 Cell Line
por: Sharifi, Laleh, et al.
Publicado: (2019)

Propolis anti-inflammatory effects on MAGE-1 and retinoic acid-treated dendritic cells and on Th1 and T regulatory cells
por: Santiago, Karina Basso, et al.
Publicado: (2023)

Clinical significance of peripheral blood CD11b(+)/CD33(+)/HLA-DR(-) myeloid cells in infants and children with infectious diseases and increased CRP
por: Latifi, Aysan, et al.
Publicado: (2020)

Expression and prognostic relevance of MAGE-A3 and MAGE-C2 in non-small cell lung cancer
por: Chen, Xinfeng, et al.
Publicado: (2017)

Designing and developing a sensitive and specific SARS-CoV-2 RBD IgG detection kit for identifying positive human samples
por: Raoufi, Ehsan, et al.
Publicado: (2023)

A Clinical Study of a Cell-Based MAGE-A3 Active Immunotherapy in Advanced Melanoma Patients
por: Russo, Vincenzo, et al.
Publicado: (2011)

Pathogenicity of the MAGE family
por: Li, Sanyan, et al.
Publicado: (2021)

Combinational expression of tumor testis antigens NY-ESO-1, MAGE-A3, and MAGE-A4 predicts response to immunotherapy in mucosal melanoma patients
por: Freiberger, Sandra N., et al.
Publicado: (2022)

Immunological Characterization of Whole Tumour Lysate-Loaded Dendritic Cells for Cancer Immunotherapy
por: Rainone, Veronica, et al.
Publicado: (2016)

mRNA-Loaded Lipid Nanoparticles Targeting Dendritic Cells for Cancer Immunotherapy
por: Sasaki, Kosuke, et al.
Publicado: (2022)

5-aza-2’-deoxycytidine (DAC) treatment induces the MAGE-A10 expression and improves the cytotoxicity of MAGE-A10-specific CTLs in lung cancer cells
por: Li, Zhenhua, et al.
Publicado: (2020)

The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells
por: Seif, Farhad, et al.
Publicado: (2017)

Development of a CD8 co-receptor independent T-cell receptor specific for tumor-associated antigen MAGE-A4 for next generation T-cell-based immunotherapy
por: Davari, Kathrin, et al.
Publicado: (2021)

Preclinical evaluation of an affinity-enhanced MAGE-A4-specific T-cell receptor for adoptive T-cell therapy
por: Sanderson, Joseph P, et al.
Publicado: (2019)

Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy
por: Findlay, Emily Gwyer, et al.
Publicado: (2019)

Expression of tumor-specific antigen MAGE, GAGE and BAGE in ovarian cancer tissues and cell lines
por: Zhang, Shiqian, et al.
Publicado: (2010)

A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis
por: Gao, Yanzhe, et al.
Publicado: (2016)

Correction: Immunological Characterization of Whole Tumour Lysate-Loaded Dendritic Cells for Cancer Immunotherapy
por: Rainone, Veronica, et al.
Publicado: (2016)

Dendritic Cells and Their Role in Immunotherapy
por: Gardner, Alycia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mlqmkmj8lgr13sv50amdlaij1a